We have studied the concerted action of factors that in¯uence the balance between cell proliferation and cell death in the developing lens of transgenic mice. We show that a human papillomavirus type 18 (HPV18) E6/E7 transgene that predominantly expresses the viral E7 gene product triggers apoptosis in a dose dependent manner, and causes retardation of lens growth or microphakia. E7 is known to inactivate pRB, the product of the retinoblastoma gene, and to enhance the action of p53. Our earlier work had demonstrated that over-expression of p53 itself can cause apoptosis of lens cells, and that a mutant p53 allele can interfere with this process. In the present study, we examined lenses that simultaneously express dierent constellations of the HPV18 E6/E7, wild-type and mutant human p53, and wild-type human pRB transgenes. We observed that lens cells expressing the HPV18 transgene are more sensitive to wild-type human p53 action than normal lens cells. As a result, there is severe microphakia in lenses that express both the HPV18 and the wild-type p53 transgenes. By contrast, apoptosis was reduced in lenses that coexpressed the HPV18 and either the pRB or the mutant p53 transgene. We conclude that levels of wild-type p53 are critical, and that any excess of p53 or suppression of pRB can cause cell death. Our results encourage attempts to counteract the deleterious action of human papillomaviruses in cervical cancer by a combination of measures that decrease cell proliferation and enhance apoptosis.
Introduction
A strong causal relationship links HPV types 16 and 18 with cervical cancer (DuÈ rst et al., 1983; Boshart et al., 1984) . The E6 and E7 open reading frames of HPV type 16 (Yasumoto et al., 1986; Tsunokawa et al., 1986; Yutsudo et al., 1988; Kanda et al., 1988; MuÈ nger et al., 1989) and type 18 Romanczuk et al., 1991; Woodworth et al., 1992) encode transforming proteins. The genes encoding these proteins are selectively retained and expressed in cervical carcinomas (Schwarz et al., 1985; SchneiderGaÈ dicke and Schwarz, 1986; Smotkin and Wettstein, 1986) . Thus E6 and E7 appear directly tied to cervical cancer. Both gene products are small, nuclear proteins that possess paired Cys-x-x-Cys motifs capable of binding zinc (Schneider-GaÈ dicke and Schwarz, 1986; Barbosa et al., 1989) . The E6 protein can bind double stranded DNA with high anity (Grossman et al., 1989) and exhibits transactivation activity (Sedman et al., 1991) . Similarly, the E7 protein can transactivate the adenovirus E2 promoter (Phelps et al., 1988) . Moreover, the E6 protein targets the proteolysis of p53 through the ubiquination pathway Schener et al., 1990) , whereas the E7 protein binds pRB (Dyson et al., 1989) and, in so doing, releases E2F (Chellappan et al., 1992) , which leads the cell to S-phase entry and p53-dependent apoptosis (Wu and Levine, 1994; Qin et al, 1994; Almasan et al., 1995) . There have been several reports of HPV-induced malignancy in transgenic mice bearing HPV16-E6 and E7 oncogenes (Kondoh et al., 1991; Griep et al., 1993; Arbeit et al., 1993) . While it is evident in the mouse model that HPV16- (Sasagawa et al., 1992; Arbeit et al., 1994; Auewarakul et al., 1994) and HPV18- (Greenhalgh et al., 1994; Comerford et al., 1995) associated malignancy proceeds through multiple stages, the precise sequence of events and the factors determining the rate of progression to high grade dysplasia and invasive cancer have not been identi®ed. Based on presently available data, one may postulate that E6 oncoproteins induce the degradation of p53 and inhibit the p53-dependent apoptosis pathway while E7 oncoproteins bind and inactivate pRB and thereby stimulate the cell cycle (Schener et al., 1991; Morgenbesser et al., 1994; White, 1994; Griep, 1994, 1995; Howes et al., 1994; Fromm et al., 1994) . In this scenario, the normally well balanced equilibrium between proliferation and apoptosis is shifted toward uncontrolled growth.
Over-expression of wild-type p53 in cells that have lost balanced growth control has been proposed as an attractive approach to treat cancer (Fisher, 1994) . Unfortunately, no suitable animal model exist that would allow the introduction of a wild-type p53 transgene in cervical epithelial cells, the natural target of HPV oncogene action. This is because there is no promoter available that speci®cally targets cervical epithelial cells. We are fortunate though to have access to a promoter that targets the lens, an organ that is entirely composed of epithelial cells. This has enabled us to establish a lens model in which the in vivo interaction of factors that in¯uence the balance between epithelial cell proliferation and cell death can be readily studied. Oncogenes or tumor suppressor genes are speci®cally targeted to the developing lens with the help of a promoter derived from the murine aA-crystallin gene (Mahon et al., 1987; Nakamura et al., 1989 Nakamura et al., , 1995 . Our previous experiments had shown that over-expression of human wild-type p53 causes lens cell apoptosis, and that a mutant p53 gene isolated from human tumor cells can counteract this eect (Nakamura et al., 1995) . The present study was designed to monitor the single and combined eects of HPV18 oncogene products, pRB and mutant and wild-type p53 on lens development.
Results
Genotypes and phenotypes of aHPV18 and aRB transgenic mice Figure 1 shows schematic drawings of the transgene constructs that were introduced in the mouse germ line via zygote microinjection. Figure 1a depicts the aHPV18 construct containing the E6E7 coding sequence under the control of the lens-speci®c maA crystallin promoter. A bacterial IoxP site is intercalated between the promoter and the gene. Figure 1b indicates the primers used to distinguish the two mRNA moieties generated by dierential splicing of the HPV18 gene. Figure 1c shows the structure of the aRB gene, a human retinoblastoma gene made lensspeci®c by attaching it to the maA promoter.
An aHPV18 strain was generated carrying a multicopy integration site of the transgene (Figure 2 , lanes 1 and 2). Exposure of this multicopy integration site to the CRE recombinase allows excision of sequences between IoxP sites and thereby reduction in transgene copy number. Following a protocol previously established in our laboratory (44), (Lakso et al., 1997) we crossed the multicopy aHPV18 strain with the EIIa-cre strain and obtained progeny with genetically ®xed reduction of transgene copy numbers. Substrains r-1 (lanes 3 and 4) and r-2 (lanes 5 and 6) contain drastically reduced levels of transgene DNA.
Size dierences allowed us to distinguish between dierent mRNA moieties transcribed from the aHPV18 transgene (see Figure 1b) . RT ± PCR analysis of lens αHPV18 r-1 r-2 αHPV18r Figure 2 Southern blot of tail DNA derived from dierent transgenic mice identi®ed on top. DNA samples were digested with BglII that cuts outside the aHPV18 transgene sequence. Note that the aHPV18 strain contains 410 transgene copies at one integration site. The transgene copy number at this integration site has been drastically reduced in the r-1 and even more so in the r-2 strain 800bpE6E7 -600bpE6*E7 --800bpE6E7 (7) Reverse Transcriptase(RT). The RNA was derived from individuals of the aHPV18 strain, or the aHPV18r reduction strains r-1 and r-2, as indicated on top. Lanes 9 and 10 show RT ± PCR reactions with lens DNA. RT ± PCR of the aHPV18 construct is shown in lane 11. Note that both the aHPV18 and the aHPV18r reactions contain some 800 bp E6E/E7, but mostly 600 bp E6*E7 PCR products. (b) Northern blot analysis of total lens RNA derived from individual littermates of adult aRB transgenic mice or non-transgenic (NT) controls as indicated on top. The size of RNA detected in aRB individuals corresponds to the known size of human pRB mRNA (4.5 kb). The 18S ribosomal RNA band served as a loading control RNA derived from adult aHPV18 and aHPV18r mice con®rmed the presence of a fainter band of full-length E6E7 mRNA and a more predominant band of E6*E7 mRNA ( Figure 3a ). The former is thought to be the main source of E6, the latter of E7 oncogene products (Smotkin et al., 1989) . This internally controlled PCR assay very likely re¯ects a quantitative dierence, that is, a strong E7 and a weaker E6 expression by the aHPV18 transgene. Northern analysis of aRB lens RNA revealed an aRB transcript with the predicted size of 4.5 kb ( Figure 3b ). The histology of aRB and aHPV18 lenses is shown in Figure 4 . No abnormality was detected in aRB mice (compare panels A and B). By contrast, multicopy aHPV18 developed mild central cataracts following a defect in primary lens ®ber dierentiation during development (panels C and E). Reduction of aHPV18 copy number, and thereby the dosage of E6E7 gene products, eliminated this defect in primary ®ber dierentiation (panels D and F). The phenotype of the aHPV18 mouse is very consistent, based on the observation of at least three individuals at four dierent time points of postnatal development (0, 1, 6 and 10 weeks of age). The fact that primary, but not secondary, ®ber dierentiation is aected underscores the well documented ontogenic dierences between these two types of lens ®bers.
The eect of p53 and HPV18 E6/E7 coexpression on lens development
We wished to examine the eects of wild-type or mutant p53 transgene expression on the aHPV18 lens phenotype. For this purpose we set up matings between the aHPV18 strains and our previously generated W1 and M1 strains that express lens-targeted wild-type and mutant human p53, respectively (Nakamura et al., 1995) . The histology of adult eyes derived from transgenic parents or compound hemizygous progeny is shown in Figure 5 . The hemizygous W1 lens (panel D) Figure 4 Paran embedded sections of newborn eyes stained with H&E. The anterior of the eyes is pointing upwards. The eyes are derived from non-transgenic (NT, a), aRB (b), aHPV18 (c) and aHPV18r (d) individuals, respectively. Also shown are high magni®cations of the equatorial region of the aHPV18 (e) and the aHPV18r lens (f). No abnormality is detected in aRB transgenics (b). The multicopy aHPV18 lens shows a central cataract indicating a defect in primary ®ber dierentiation (c). The arrowheads in e point to pycnotic or fragmented nuclei, typical for an apoptotic defect. Note that a reduction of aHPV18 transgene copy number is re¯ected by a partial rescue of central apoptosis (f) and lens size (compare c and d). Bar=200 mm is characterized by a defect in secondary ®ber development due to apoptosis caused by the overexpression of a human wild-type p53 gene (Nakamura et al., 1995) . The aHPV18 lens appeared normal (compare panels A and B), except for a faint central cataract (only seen at higher magni®cation) that we describe above. By contrast, the compound hemizygous aHPV18/W1 animals showed pronounced bilateral reduction in lens size, or microphakia (panel C), comparable to the severe apoptotic phenotype of the homozygous W1/W1 lens (panel F). These observations clearly show that the eects of the aHPV18 and W1 transgene products are not simply additive, and strongly suggest the presence of a pathway that enables the viral oncogene products to enhance p53-dependent apoptosis.
Our previous study has shown that a mutant p53 allele found in human cancers can rescue the apoptotic defect of W1 animals expressing the human wild-type p53 allele (Nakamura et al., 1995) . The M1 strain of transgenic mice expressing the mutant p53 allele is characterized by a virtually normal lens phenotype (panel E). A comparison of panels D and G demonstrates the rescue eect of the mutant p53 allele. As expected, neither microphakia nor abnormal growth was observed in the aHPV18/M1 compound hemizygous lens (panel H). However, compound hemizygous aHPV18/W1/M1 lenses showed pronounced microphakia (panel I). Cell death in this triple transgenic scenario most likely results from the fact that E7 expressed by aHPV18 down-regulates endogenous pRB, thereby decreasing the threshold of wild-type p53 necessary to cause apoptosis.
In an eort to determine whether HPV oncogene products trigger cell apoptosis in the developing embryonic lens, we performed TUNEL staining as shown in Figure 6 . Strong apoptosis in lens cells of the W1 eye served as a positive control (compare panel G with the control shown in panel H). Positive staining indicative of cell apoptosis is seen in both the aHPV18 and the aHPV18r lens (panels A and B). That this apoptosis is triggered by endogenous p53 is strongly suggested by the fact that the mutant p53 allele, known to have a dominant negative eect on wild-type gene function (Nakamura et al., 1995) , abrogated positive TUNEL staining (panel C). By contrast, apoptosis is not eliminated in the aHPV18/W1/M1 lens (not shown), indicating that wild-type p53 concentrations in this triple transgenic lens have reached a threshold level that triggers apoptosis. HPV18 E7, the predominant product of the aHPV18 transgene (see Figure 3a) , binds pRB and thereby triggers p53-mediated apoptosis (Dyson et al., 1989; Chellappan et al., 1992; Wu et al., 1994; Qin et al., 1994; Almasan et al, 1995) . We predicted therefore, that an exogenous supply of pRB would abrogate HPV18-mediated apoptosis. Indeed, there is no TUNEL staining in the compound hemizygous aHPV18/aRB lens (panel E). Since both aHPV18 and wild-type p53 transgene expression triggers apoptosis, strong TUNEL staining in the compound hemizygous aHPV18/W1 lens (panel D) comes as no surprise. This additive eect of two dierent transgenes also explains why exogenous pRB is unable to prevent apoptosis in the compound hemizygous aHPV18/W1/aRB lens (panel F). Increased lens cell apoposis does not necessarily lead to severe defects in ®ber development. Figure 6 shows comparable degrees of apoptosis in aHPV18, aHPVr and W1 lenses, yet only in the latter is development severely aected in the adult ( Figure 5 ). The outcome of apoptotic action is presumably decided by the threshold level of transgene products attained prior to ®ber elongation.
Eye ball weight parallels that of the lens throughout vertebrate development (Coulombre and Coulombre, 1964) . This fact allowed us to use the weight of the eyeball as a quantitative measure of lens cell apoptosis in our transgenic animals. Figure 7 depicts the results of our weight measurements in 6, 10 and 24 week-old animals, respectively. All transgenic eyes represented in this study weigh less than the age-matched nontransgenic controls, and the weight reduction parallels the degree of apoptosis observed during lens development.
This holds for the apoptosis inducing W1(wild-type p53) as well as for the aHPV18 transgene. Eyeballs of aHPV18/W1 animals weigh less than those of W1 animals, indicating that aHPV18 lens cells are more sensitive to wild-type human p53 action than normal lens cells. This increased sensitivity is still noted in triple transgenic lens cells that contain aHPV18, W1 and M1 alleles (panel A). Panel B shows that allele dosage eects of wild-type human p53 on eyeball weight are readily apparent (compare W1 with W1/W1 eyes). Also, a reduction of aHPV18 transgene copy number reduces the sensitivity of the lens cell to human wild-type p53-mediated apoptosis (compare the weights of aHPV18/W1 and aHPV18r/W1 eyeballs). This suggests that the degree of apoptosis is eected by the amount of HPV18 E7 present in the lens cell, and its in¯uence on the balance between pRB and p53 levels. While we do not yet have sucient numbers of Figure 6 TUNEL staining of apoptotic nuclei in the equatorial zone of the neonate lens. Shown are paran embedded sections of aHPV18 (a), aHPV18r (b) aHPV18/M1 (c), aHPV18/W1 (d), aHPV18/RB (e), aHPV18/W1/RB (f), W1 (g) and non-transgenic lenses (h). Staining (brown color) is clearly discernible in cell nuclei depicted in panels a, b, d, f and g. Note that aHPV18 lens cell nuclei are TUNEL positive, and that human mutant p53 and human wild-type pRB suppress apoptotic staining. Refer to the text for more details. Bar=100 mm age-matched aHPV18/W1/aRB individuals to include them in this study, we expect to see in due time that the aRB allele measurably counteracts the eects of the aHPV18 and W1 alleles.
Discussion
Our data show that the aHPV18 gene primarily directs low expression of the E6 viral oncogene and high expression of the E7 viral oncogene to the developing lens of our transgenic mice. We observe TUNEL staining in lens cells of aHPV18 newborns, consistent with earlier reports that the main expression product, E7, triggers apoptosis via loss of pRB function, release of E2F, and enhancement of p53 action (Chellappan et al., 1992; Wu and Levine, 1994; Qin et al., 1994; Almasan et al., 1995; Morgenbesser et al., 1994) . Using CRE recombinase-mediated reduction of transgene copy numbers, we were able to show that the eect of the HPV18 transgene on lens apoptosis is dose dependent. The function of HPV18 E7 resembles that of HPV16 E7 tested under similar circumstances Griep, 1994, 1995) . Why the RNA encoding E7 is the predominant splice product of the viral E6/E7 transgenes in the developing lens is not known. Of a number of mouse strains carrying HPV16 E6/E7 transgenes directed to the lens, only one has been reported to develop lens tumors at low frequency, indicative of high levels of HPV16 E6 action (Kondoh et al., 1991) . This particular mouse strain carried an HPV16 E6/E7 transgene, suggesting that the speci®cs that distinguish two otherwise closely related viruses may account for the observed dierences in E6/E7 ratios.
The adenovirus E1A oncogene has also been reported to induce apoptosis, as observed in primary rodent cells (Rao et al., 1992; Debbas and White, 1993; Lowe and Ruley, 1993; Lowe et al., 1994) . Likewise, a mutant SV40 T antigen that is unable to form a complex with p53 but retains the ability to bind pRB, induces apoptosis of thymocytes in irradiated transgenic mice (McCarthy et al., 1994) .
Con®rming our earlier studies (Nakamura et al., 1995) , the present study shows that over-expression of a wild-type human p53 transgene causes apoptosis of lens cells during development, thus impeding lens growth and resulting in microphthalmia. This eect correlates with transgene dosage since the eect is much more pronounced in W1/W1 animals than in W1 individuals. This shows that normal lens cells cannot withstand the powerful apoptotic action of p53. Yet, the p53 eect is much more drastic in lens cells that also express the aHPV18 transgene as our comparison of W1 and aHPV18/W1 eyes shows. This points to a window of opportunity with respect to a possible elimination of HPV-positive tumor cells in patients. If wild-type p53 could be administered at dosages that would primarily aect HPV18 oncogene-expressing cells, cervical cancers could conceivable become a target tissue of p53 tumor suppressor therapy. Such therapy could be especially eective at early stages of HPV oncogenesis, i.e., before cell populations begin to predominate that carry a mutation in the patient's endogenous p53 as this would counteract the therapeutic eect of exogenous wild-type p53. Obviously, if there were a possibility to selectively suppress E6 expression in these tumors, that would also increase apoptosis and thereby suppress tumor growth.
The retinoblastoma gene product has also been envisaged as a possible tumor suppressor based on growth retardation observed in tumor cells expressing exogenous pRB (Huang et al., 1988) . Unfortunately, our lens model does not support this view. We ®nd that wild-type human pRB actually down-regulates p53-dependent apoptosis, as recent observations had already suggested (Morgenbesser et al., 1994; White, 1994; Haupt et al., 1995; Haas-Kogan et al., 1995) . This would also explain why RB-reconstituted tumor Figure 7 Mean weight comparisons of eyeballs derived from 6 (white), 10 (gray) or 24 (black) week-old transgenic mice. Weight loss compared to the NT (nontransgenic) controls indicates lens cell apoptosis. Genotypes are listed at the bottom. (a) Apoptotic eects of the aHPV18 allele are increased by the simultaneous presence of the W1 allele and the W1 eect is still noted in the triple constellation of aHPV18, W1 and M1 alleles. (b) Apoptotic eects are dependent on W1 and aHPV18 gene dosage, respectively. Note that the eyeball weight of W1/W1 homozygous animals is roughly half that of the hemizygous W1 animals. Likewise, eyes of aHPV18/W1 individuals weigh less than those of aHPV18r/W1 animals cells at times continue to be tumorigenic (Zhou et al., 1994) .
Our aHPV18 line may become quite useful in a search for other factors that act in a multistep pathway of in vivo tumorigenesis in an epithelial tissue. Thus, our study may contribute both to basic research on the genetics of carcinogenesis, and to future schemes of gene-based therapy aimed at decreasing cell proliferation and increasing cell death.
Materials and methods

Transgene construction and production of transgenic mice
The aHPV18 transgene was built from the previously described maA-loxP-TAg construct (Lakso et al., 1996) by inserting an HPV18 E6/E7 open reading frame derived from p18-L67A Romanczuk et al., 1991) . The BglII ± HindIII HPV18 E6/E7 insert was generated by PCR, using the 5' primer GGAGA TCTGAAACACACCACTACTATGGCG and the 3' primer GGAAGCTTTGTTGCTTACTGCTGGGATGCA-CA. The insert was ampli®ed using 35 cycles of (1 min at 958C, 1 min at 688C, and 2 min at 728C). After veri®cation by DNA sequencing, the insert was introduced between a BamHI site located upstream of the ATG codon and a HindIII site created downstream of the TAA codon in the TAg coding region. An NciI digest yielded a 2.17 kb aHPV18 transgene that was puri®ed and microinjected into zygotes to generate a multicopy aAHPV18 transgenic mouse strain. The aRB transgene was derived from the previous described aAhp53wt construct (Nakamura et al., 1995) by removing a BamHI fragment of human p53 and inserting in its place a BamHI fragment derived from pJ3OHRbC (Robbins et al., 1990) encoding human wildtype pRB. A 5.74 Kb XbaI ± XhoI fragment was puri®ed to generate the multicopy aRB transgenic mouse strain.
Genotype analysis of tail DNA by Southern blotting
High molecular weight DNA was isolated from the tail tips of transgenic mice and analysed by Southern-blot hybridization. Two mg of tail DNA were digested with BglII that cuts outside the aHPV18 transgene sequence. The digested DNAs were electrophoresed through 0.8% agarose gels, and transferred in 106SSC to a nylon membrane (Nytran, Schleicher and Schuell) in 106SSC according to manufacturers' instructions. The membrane was pre-hybridized at 658C for 15 min in QuikHyb Hybridization Solution (Stratagene). Random primed, 32 P-labeled aHPV18 probe was added to membrane, hybridization was for 1 h at 658C and the ®nal stringent wash was for 30 min at 688C in 0.26SSC/0.1% SDS. The membranes were exposed overnight to Kodak XAR-5 ®lm.
Analysis of aHPV18 transgene expression by RT ± PCR
Lenses were dissected and immediately placed on dry ice. Total RNA was extracted using RNAzol TM (Tel-Test) according to the manufacturer's protocol. Total lens RNA was treated with RNase-free DNaseI (Boehringer Mannheim) to remove any residual DNA. One half of the total RNA from two lenses of each transgenic mouse was subjected to RT ± PCR, using the SuperScript Preamplification System (GibcoBRL) for ®rst strand cDNA synthesis as instructed by the manufacturer. The other half of the lens RNA was used for a control assay minus RT. The 5' primer A (Figure 1b) was ATGGCGCGCTTTGAGGATC-CA, the 3' primer B was CTGGGATGCACACCACGGA-CA. Ampli®cation was carried out in a Perkin-Elmer Thermal Cycler using the following cycle 35 times: 1 min, 958C; 1 min, 688C; and 2 min, 728C. Twenty ml of the 100 ml total reaction volume were electrophoresed through 1.5% agarose gels, and subsequently transferred to nylon membranes for Southern blotting as described above.
Analysis of human wild-type pRB expression by Northern blotting
Total RNA of transgenic lenses was extracted as described above. Total RNA from each transgenic mice was electrophoresed in a formaldehyde/formamide/1% agarose gel, blotted and hybridized to 32 P-labeled probes derived from a 5' portion of the pRB BamHI fragment. Hybridization was performed at 658C and the ®nal stringent wash was at 688C in 0.26SSC/0.1% SDS. Equal loading and integrity of RNA were con®rmed by crosshybridization with 18S ribosomal RNA and ethidium staining.
Histological analysis
The eyes were ®xed in 10% formalin/phosphate-buered saline, embedded in methacrylate (Figures 5) or paran (Figures 4 and 6) , sectioned vertically parallel to the optical axis and stained with hematoxylin/eosin.
Detection of apoptosis by terminal deoxynucleotidyl transferasemediated dUTP-biotin nick-end labeling (TUNEL)
For in situ analysis (Figure 6 ), eyes were ®xed in 10% formalin, paran embedded and cut into 5 mm sections. Sections were incubated with 50 units/100 ml terminal deoxynucleotidyl transferase and 1 nmol/100 ml biotin-16-dUTP (Boehringer Mannheim) as described (Gavrieli et al., 1992) . Biotin incorporation was detected with an avidinbiotin peroxidase complex reagent (Vector Laboratories), followed by visualization with diaminobenzidin-H 2 O 2 (Sigma Immuno Chemical). Sections were counterstained with 1% methyl green solution.
Analysis of eyeball weight
The eyeballs were ®xed in 10% formalin for 1 week and weighed. Mean weight and standard deviation were calculated and analysed by Stat View (Abacus Concepts).
